Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Khera, H. Won, G. Peloso, Kim Lawson, Traci Bartz, Xuan Deng, E. Leeuwen, P. Natarajan, C. Emdin, A. Bick, A. Morrison, Jennifer Brody, N. Gupta, A. Nomura, T. Kessler, S. Duga, J. Bis, C. Duijn, L. Cupples, B. Psaty, D. Rader, J. Danesh, H. Schunkert, R. McPherson, M. Farrall, H. Watkins, E. Lander, James Wilson, A. Correa, E. Boerwinkle, P. Merlini, D. Ardissino, D. Saleheen, S. Gabriel, S. Kathiresan (2016)
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.Journal of the American College of Cardiology, 67 22
M. Trinder, G. Francis, L. Brunham (2020)
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular DiseaseJAMA Cardiology, 5
J. Ascaso, F. Civeira, C. Guijarro, J. Miranda, L. Masana, J. Mostaza, J. Pedro-botet, X. Pintó, P. Valdivielso (2019)
Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Society of Arteriosclerosis (SEA), 2019Clínica e Investigación en Arteriosclerosis (English Edition)
S. Pérez-Calahorra, M. Laclaustra, V. Marco-Benedí, I. Lamiquiz-Moneo, J. Pedro-botet, N. Plana, R. Sánchez-Hernández, A. Amor, F. Almagro, F. Fuentes, Manuel Suarez-Tembra, F. Civeira (2019)
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.Atherosclerosis, 284
J. Mosley, D. Gupta, Jingyi Tan, J. Yao, Q. Wells, C. Shaffer, S. Kundu, C. Robinson-Cohen, B. Psaty, S. Rich, W. Post, Xiuqing Guo, J. Rotter, D. Roden, R. Gerszten, Thomas Wang (2020)
Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.JAMA, 323 7
Letters 3. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral CI, 0.49-3.48; without crossover: OR, 1.76; 95% CI, 1.02-3.04; randomized investigation in ST-segment elevation acute coronary syndrome: P = .56). Other baseline variables included in the model, ie, sex, the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in diabetes, hypertension, height, and creatinine clearance, were ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60(24): also not independently associated with bleeding. 2481-2489. doi:10.1016/j.jacc.2012.06.017 Agostini et al have listed reasons for failure to complete 4. Lo TS, Nolan J, Fountzopoulos E, et al. Radial artery anomaly and its influence on transradial coronary procedural outcome. Heart. 2009;95(5):410- the procedure via RA and propose strategies to remedy this 415. doi:10.1136/hrt.2008.150474 problem. We acknowledge their comments and suggestions to 5. Le May MR, Singh K, Wells GA. Efficacy of radial versus femoral access in the improve procedural success. The sheath used in the SAFARI- acute coronary syndrome: is it the operator or the operation that matters? JACC STEMI trial was the Glidesheath Introducer Sheath (Terumo), Cardiovasc Interv. 2015;8(11):1405-1409. doi:10.1016/j.jcin.2015.06.016 which has a hydrophilic coating facilitating smooth inser- tion. Verapamil was also administered routinely via the sheath to reduce radial artery spasm.
JAMA Cardiology – American Medical Association
Published: Dec 16, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.